oxyphenbutazone has been researched along with Cancer of Pharynx in 2 studies
Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| COCCHI, U | 1 |
| Serin, D | 1 |
2 other studies available for oxyphenbutazone and Cancer of Pharynx
| Article | Year |
|---|---|
[Preliminary report on experiences with oxyphenbutazone (Tanderil) in roentgen-irradiated patients with tumors of the mouth, pharynx and larynx].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Humans; Laryngeal Neoplasms; Larynx; Mouth Neopl | 1963 |
[Trial of Tandearil in prevention of cutaneous and mucosal complications in patients with otorhinolaryngeal neoplasms treated by irradiation].
Topics: Ear Neoplasms; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Nose Neoplasms; Oxyphenbutazone | 1976 |